Welcome to our dedicated page for Aramark US SEC filings (Ticker: ARMK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aramark (NYSE: ARMK) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Aramark is a Delaware-incorporated food service and facilities management company headquartered in Philadelphia, Pennsylvania, with common stock registered under Section 12(b) of the Exchange Act and listed on the New York Stock Exchange under the symbol ARMK.
Through this page, readers can review Aramark’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically contain information about revenue, operating income, segment performance, cash flow, leverage ratio, and risk factors. These filings also describe the company’s North American and international food and support services operations, major lines of business, and key accounting and reporting policies.
Aramark’s current reports on Form 8-K document material events such as earnings releases, results of operations, and changes to its credit agreements. Recent 8-K filings have detailed amendments to the company’s credit agreement, including the repricing and refinancing of U.S. Term B loans with maturities extending into 2028 and 2030, and furnished press releases announcing quarterly and annual financial results.
The company’s definitive proxy statement on Schedule 14A provides insight into governance and executive compensation, including proposals submitted to shareholders, performance metrics used in incentive plans, and information about the annual meeting. This document discusses topics such as revenue and profitability growth, net new business, leverage ratio, and cash flow, and includes reconciliations of non-GAAP measures to GAAP where applicable.
Stock Titan enhances these filings with AI-powered summaries designed to explain complex sections in simpler terms. Users can quickly identify key points from lengthy documents, such as trends in Aramark’s revenue and operating income, changes in leverage and capital structure, and the rationale behind amendments to its credit facilities. The filings page also surfaces Form 4 insider transaction reports when available, allowing investors to track share transactions by directors and officers alongside the company’s broader financial and strategic disclosures.
Lauren A. Harrington, SVP and General Counsel of Aramark (ARMK), was credited with 61.939 shares as dividend equivalent rights related to restricted stock units on 08/20/2025, recorded at a $0 price. After this accrual, the reporting person beneficially owned 96,929.029 shares. The filing states these dividend equivalent rights vest on the same schedules as the underlying restricted stock unit awards. The Form 4 was signed by an attorney-in-fact on 08/21/2025.
Aramark (ARMK) Form 4: Marc A. Bruno, COO U.S. Food & Facilities and an officer of Aramark, reported an acquisition on 08/20/2025. The filing shows 72.048 shares were acquired at $0, described as dividend equivalent rights that vested in connection with the issuer's quarterly dividend and accrued to the reporting person on restricted stock units.
Following the transaction, the reporting person beneficially owns 259,095.274 shares. The Form 4 was signed by an attorney-in-fact on 08/21/2025. The filing indicates these dividend equivalents vest on the same schedule as the underlying restricted stock unit awards.
Aramark (ARMK) Form 4 — insider acquisition via dividend equivalents
Senior Vice President & Chief HR Officer Abigail Charpentier was reported as acquiring 64.783 shares of Aramark common stock on 08/20/2025 at a reported price of $0, described as dividend equivalent rights that vested with underlying restricted stock units. After the transaction, the reporting person beneficially owned 54,056.256 shares. The filing was signed by an attorney-in-fact on 08/21/2025. The entry indicates these are non-cash, compensation-related share credits tied to quarterly dividends and the vesting schedule of the underlying awards.
John J. Zillmer, Director and Chief Executive Officer of Aramark (ARMK), reported a non‑derivative acquisition on 08/20/2025 of 721.338 shares of Aramark common stock at a reported price of $0. After the transaction the filing lists 832,546.749 shares beneficially owned by the reporting person. The filing states these shares represent dividend equivalent rights that accrued on restricted stock units and vest on the same schedule as the underlying awards.
The Form 4 was signed by an attorney‑in‑fact on 08/21/2025. No cash purchase price was reported because the grant reflects dividend equivalents tied to existing restricted stock units rather than an open‑market purchase or sale.
Greg Creed, a director of Aramark (ARMK), reported a Form 4 disclosing awards that vested on 08/20/2025. The filing records the acquisition of 155.111 dividend equivalent rights related to deferred stock units at a $0 price. Following the transaction, the reporting person beneficially owns 58,282.323 shares directly and 12,475 shares indirectly through a trust. The filing explains these amounts represent dividend equivalents that vest on the same schedule as the underlying deferred stock units.
Karen Marie King, a director of Aramark (ARMK), reported a non‑derivative acquisition on 08/20/2025. The filing shows 29.912 shares were acquired at $0 as dividend equivalent rights credited on deferred stock units; these rights vest on the same schedule as the underlying awards. After the transaction, the reporting person beneficially owned 37,614.967 shares directly. The report was signed by an attorney‑in‑fact on 08/21/2025.
Bridgette P. Heller, a director of Aramark (ARMK), reported a non‑derivative acquisition on 08/20/2025. The Form 4 shows 79.515 shares acquired at $0, recorded as dividend equivalent rights that accrued on deferred stock units and vest on the same schedule as the underlying awards. Following the reported transaction, the filing lists 30,416.4 shares beneficially owned in a direct form. The filing was submitted by one reporting person and signed by an attorney‑in‑fact on 08/21/2025. The report includes the reporter's address at Aramark's Philadelphia office.
Patricia E. Lopez, a director of Aramark (ARMK), acquired 62.2 shares on 08/20/2025 through dividend equivalent rights that vested on deferred stock units she holds. The reported transaction shows a $0 per-share price and leaves the reporting person with 23,792.883 shares beneficially owned in a direct form. The filing clarifies these were dividend equivalent rights tied to the issuer's quarterly dividend and that such rights vest on the same schedule as the underlying awards. The Form 4 was signed by an attorney-in-fact on 08/21/2025.
Kevin Wills, a director of Aramark (ARMK), reported a Form 4 filing showing an internal award-related acquisition dated 08/20/2025. The filing states 29.129 shares were acquired at $0 as dividend equivalent rights that accrued on deferred stock units held by the reporting person. After the reported transaction the filing shows the reporting person beneficially owning 16,696.312 shares. The filing explains these dividend equivalent rights vest on the same schedule as the underlying awards and were reported by an attorney-in-fact on 08/21/2025.
Stephen I. Sadove, a director of Aramark (ARMK), reported an internal transaction dated 08/20/2025 showing acquisition of 210.525 dividend-equivalent rights related to deferred stock units at a $0 price. After the transaction he beneficially owned 94,042.121 shares directly and 15,000 shares indirectly through a trust. The filing explains these dividend-equivalent rights vest on the same schedule as the underlying awards. The Form 4 was signed by an attorney-in-fact on 08/21/2025.
FAQ
What is the current stock price of Aramark US (ARMK)?
What is the market cap of Aramark US (ARMK)?
